Company page
Neovacs Sa
Neovacs SA is a public company listed on the French market under the ticker ALNEV. The company has a market capitalization of approximately €364,509. Neovacs focuses on developing innovative therapeutic solutions, particularly in the field of immunotherapy.
- Ticker
- ALNEV:EURONEXT
- Asset type
- Stock
- Market cap
- $364,509
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR